Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Pediatr Diabetes. 2016 Jul;17(Suppl 22):73–77. doi: 10.1111/pedi.12325

Figure 1.

Figure 1

Timeline of previous and on-going studies in Skåne. The Skåne study in newly diagnosed children with diabetes (start 1995) was succeded by the national Better Diagnosis Study. In the Diabetes Prediction in Skåne (DiPiS) study, we were screening newborn children for risk genes during four years (2000–2004) and follow a risk cohort up to 15 years of age. The Environmental Determinant of Diabetes in the Young (TEDDY) screened newborn children between September 2004 and Februrary 2010 and follow risk children to 15 years of age. The Diabetes Pevention-Immune Tolerance (DiAPREV-IT) and DiAPREV-IT 2 are two secondary prevention studies on autoantibody-positive children. Both are still blinded.